LongBio Pharma (Suzhou) Co., Ltd. (HKG:1779)
Hong Kong · Delayed Price · Currency is HKD 142.80
+2.80 (2.00%)
Jun 18, 2026, 4:08 PM HKT
LongBio Pharma (Suzhou) Market Cap
LongBio Pharma (Suzhou) has a market cap or net worth of 10.39 billion as of June 18, 2026.
Market Cap
10.39B
Enterprise Value
10.22B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
142.80
Market Cap Chart
Since June 5, 2026, LongBio Pharma (Suzhou)'s market cap has increased from 9.78B to 10.39B, an increase of 6.22%. That is a compound annual growth rate of 444.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 10.39B | - |
| Jun 17, 2026 | 10.39B | -1.62% |
| Jun 16, 2026 | 10.56B | -0.35% |
| Jun 15, 2026 | 10.59B | -0.76% |
| Jun 12, 2026 | 10.68B | 1.41% |
| Jun 11, 2026 | 10.53B | 3.20% |
| Jun 10, 2026 | 10.20B | -1.65% |
| Jun 9, 2026 | 10.37B | 12.74% |
| Jun 8, 2026 | 9.20B | -5.92% |
| Jun 5, 2026 | 9.78B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TenNor Therapeutics (Suzhou) | 13.30B |
| TransThera Sciences (Nanjing) | 12.19B |
| Ascentage Pharma Group International | 12.18B |
| Nanjing Leads Biolabs | 10.99B |
| GenFleet Therapeutics (Shanghai) | 10.40B |
| Ascletis Pharma | 10.08B |
| HBM Holdings | 9.74B |
| CARsgen Therapeutics Holdings | 9.25B |